Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP707395.RAZWkQEqrS0cCRlOd_1LF-FEl5IsFgurn0zerO-C4qICE130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707395.RAZWkQEqrS0cCRlOd_1LF-FEl5IsFgurn0zerO-C4qICE130_provenance.
• NP936083.RA6ODUVYOMMmNCib2LXwdDE3Xl6tJ1W9q1kZtJnbzxVug130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936083.RA6ODUVYOMMmNCib2LXwdDE3Xl6tJ1W9q1kZtJnbzxVug130_provenance.
• NP664379.RAGSXjKGfpE2vx9ngIMfZVaamMTFIYkkm5O8UEX7daPkg130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664379.RAGSXjKGfpE2vx9ngIMfZVaamMTFIYkkm5O8UEX7daPkg130_provenance.
• NP508518.RA0UVwmapxcG3jly4kabpHdgS4LpvYX5TJfQR5eUs406Q130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508518.RA0UVwmapxcG3jly4kabpHdgS4LpvYX5TJfQR5eUs406Q130_provenance.
• NP509140.RAESvmGGG8LJuW4BN4MBdKNS1_DiswINROdOqXFQ17a6o130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509140.RAESvmGGG8LJuW4BN4MBdKNS1_DiswINROdOqXFQ17a6o130_provenance.
• assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP555064.RAiYSQFzS6BovYpw2ZXgFrE9tLX2lnYHKB2PgSAj-PzHQ130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555064.RAiYSQFzS6BovYpw2ZXgFrE9tLX2lnYHKB2PgSAj-PzHQ130_provenance.
• NP555067.RAng0AG_2ZLtqEh-rktEwV0dwSYJeZY05kBGkM8roRwzo130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555067.RAng0AG_2ZLtqEh-rktEwV0dwSYJeZY05kBGkM8roRwzo130_provenance.
• NP555068.RAiLpqQmcdbnONuiXM-m8bkkJKvYKzXcZ3h6Sh_LiLbgc130_assertion description "[In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555068.RAiLpqQmcdbnONuiXM-m8bkkJKvYKzXcZ3h6Sh_LiLbgc130_provenance.